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http://dx.doi.org/10.1016/j.jmu.2013Background: The use of color Doppler ultrasound (CDUS) for characterizing breast lesions has
increased in recent years. The aim of this study was to assess the value of CDUS and resistance
index (RI), in evaluating solid breast masses.
Methods: In total, 38 cases with one or more solid breast masses were enrolled. CDUS was per-
formed for each participant, evaluating RI, and all of them underwent a tissue biopsy. The
results were categorized and compared with pathology results.
Results: Malignant breast lesions were more vascular than the benign lesions. Blood vessels
were detected in 97.4% of the malignant group and only 35% of the benign group. The mean
values of RI in benign lesions and malignant lesions were 0.65  0.065 (range, 0.52e0.89)
and 0.71  0.093 (range, 0.57e0.75), respectively. The difference was just short of statistical
significance (p Z 0.061).
Conclusion: Hypervascularity of a breast mass is the most reliable sign in Doppler ultrasound to
predict its possibility of malignancy. However, it appears that the use of RI alone has little
value in differentiating between malignant and benign breast lesions. Pathological findings
are still the gold standard for diagnosing the type of breast nodules.
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Evaluating Breast Lesions using Doppler Ultrasound 93Introduction ResultsBreast cancer, the most frequently diagnosed cancer and
the leading cause of cancer death among women accounts
for 23% of all cancer cases and 14% of cancer deaths globally
[1,2]. In Iran, the age specific rate for breast cancer, the
fifth cause of cancer death, is 27.15 in 100,000 people [3].
Mammography is considered the primary screening tool
for breast cancer [4,5]. However, the sensitivity of
mammography declines with increased density of breast
tissue and it is estimated that in women with dense breasts,
the sensitivity of mammography decreases to 30e48% [6,7].
Although, there is no recommendation for routine ultra-
sound imaging currently, it has been revealed that supple-
mental ultrasound can detect small breast cancers not
detected by mammography [8e12]. A study has shown that
using ultrasound in addition to mammography increases the
sensitivity to 77.5% compared to that of mammography
alone (50%) in women with dense breasts and increased risk
of breast cancer [13].
The use of color Doppler ultrasonography (CDUS) for
characterizing breast lesions has increased in recent years.
The presence and distribution of blood vessels associated
with malignant lesions is visualized by CDUS. Doppler
criteria such as resistive index (RI), pulsatility index, and
flow velocity are used to distinguish benign from malignant
lesions. Most of the studies are based on RI comparison
between malignant and benign lesions. However, different
sensitivities, specificities, and positive and negative pre-
dictive values have been reported. [14].
The aim of this study is to assess the value of CDUS and
RI, in evaluating solid breast masses, to compare it with
pathology results, and to evaluate its potential role in
differentiating benign from malignant breast lesions.
Materials and methods
In a period of 1 year, a total of 38 patients with one or more
solid breast mass who were candidates for breast biopsy
were enrolled in this prospective cohort study. Age of the
patients ranged from 28 years to 66 years. The study was
approved by the Mashhad University of Medical Sciences
Ethics Committee (Mashhad, Iran) and informed written
consent was obtained from all patients. Clinical examina-
tion, ultrasound examination, and CDUS were performed
for each participant. All of the examinations were per-
formed by one qualified radiologist using an LN5-12 linear
transducer with a SonoAce X8 machine (Samsung Medison,
Seoul, South Korea). Doppler criteria including the size of
the lesion, presence or absence of blood vessel, degree of
vascularity compared with the surrounding normal tissue
and RI of the vessels in the lesion were evaluated. All the
participants underwent a tissue biopsy and the samples
were reviewed twice by a consultant pathologist who was
not aware of the Doppler sonographic data.
Chi-square test, Fisher’s exact test, Student t test,
ManneWhitney U test, Pearson correlation test and analysis
of variance were used for statistical analysis. A p value
of < 0.05 was considered statistically significant. Statistical
analysis was performed using SPSS version 14.0 (SPSS, Chi-
cago, IL, USA).All 38 enrolled patients completed the course of the study.
Patients were divided into two groups based on pathology
results, benign (20 cases) and malignant (18 cases). The
mean age of the patients was 43.68  10.61. There was no
statistical difference between the mean age of the two
groups diagnosed as benign and malignant (p Z 0.85).
Likewise, there was no statistical association between the
malignancy and site (p Z 0.329) or side of the mass
(p Z 0.745).
The mean size of the tumor (height  width) was
156.59  72.7 mm2 in the benign group and
266.75  153.29 mm2 in the malignant group. This differ-
ence in the size of the lesions was statistically significant
(p Z 0.012).
When all the benign and malignant lesions were pooled,
the r value (correlation coefficient) was 0.399 (pZ 0.066).
When we analyzed malignant and benign lesions separately
the correlation between the size and RI for the benign le-
sions was 0.133 (p Z 0.777) and that of malignant lesions
was 0.319 (p Z 0.246).
Doppler characteristics of the lesions were compared
between the two groups. Among the 18 malignant lesions,
17 (94%) showed vascularity and all were hypervascularized
when compared with the normal surrounding tissue.
In the benign group, vascularization was detected only in
seven lesions (35%): three with hypervascularity, two with
hypovascularity, and one showed no difference between
vascularity of the lesion and the normal surrounding tissue.
ManneWhitney was used to analyze the difference of
vascularity between the two groups. The difference was
statistically significant (p < 0.05). Fisher exact test was also
used between the groups for the degree of vascularity,
which was also statistically significant, as shown in Table 1.
The positive and negative predictive values of vascu-
larity for detecting malignancy were 70% and 92%,
respectively.
The mean values of RI in benign lesions and malignant
lesions were 0.65  0.065 (range, 0.52e0.89) and
0.71  0.093 (range, 0.57e0.75), respectively. Receiver
operating characteristic analysis was used to calculate RI.
The difference was just short of statistical significance
(p Z 0.061; Table 1). A threshold RI value of 0.625 was
obtained from this analysis. Based on this value, sensitivity
and specificity of RI values were 88% and 57%, respectively,
to predict malignancy.
Histological examinations revealed that 70% of the
benign lesions, were fibroadenoma and 83.3% of the ma-
lignant lesions were invasive ductal carcinoma.
Blood vessels were detected in 93% of the cases of
invasive ductal carcinoma and all were associated with
increased vascularity. In 36% of fibroadenomas, blood ves-
sels were also detected, 60% of which showed increased
vascularity.
Discussion
Malignant neoplasms, including those of breasts, need
angiogenesis for further growth and metastasis. Thus, a
technique such as Doppler sonography with the ability to
Table 1 The difference between the two groups based on the presence of blood vessel, vascularity, and resistive index (RI).
Benign Malignant p
Frequency (%) Frequency (%)
Blood vessel No 13 (65) 1 (5.6) <0.001
Yes 7 (35) 17 (94.4)
Degree of vascularity Increased 3 (15) 17 (94.4) 0.003
Normal 1 (5) 0 (0)
Decreased 3 (15) 0 (0)
RI, mean  SD (range) 0.650  0.065 (0.57e0.75) 0.716  0.093 (0.52e0.89) 0.061
SD Z standard deviation.
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ating benign and malignant breast lesions. This study was
designed to determine the value of Doppler sonography and
RI in distinguishing benign from malignant breast lesions.
The main finding of this study was that malignant breast
lesions are more vascular than the benign lesions, in
corroboration with previous studies [11e16]. In this study,
blood vessels were detected in 97.4% of the malignant
group and only 35% of the benign group. This difference was
statistically significant.
Another finding of our study was that there was no sta-
tistically significant difference between the mean age of
patients (44 years) in the two benign and malignant groups,
which is in line with Ozdemir et al’s [13] report. However,
some other researchers have reported significantly older
age among the malignant breast lesions compared with the
benign group [11e13]. This difference might be due to
different screening programs in different countries [14].
The importance of age emerged when Giuseppetti et al [14]
reported a correlation between the patient’s age and
Doppler findings in benign lesions, with younger women
being more likely to have hypervascular fibroadenomas and
that degenerative features of benign lesions in older
women are responsible for avascular fibroadenomas. This
indicates that the vascularity of breast lesions might be
affected by a patients’ age. The lack of significant differ-
ence between the age of malignant and benign groups in
our study allowed us to give a more realistic interpretation
of the results. That is, the occurrence of greater vascularity
in malignant lesions observed in our study could not be
attributed to the age of patients. Collectively, our results
indicate that malignant breast lesions are more likely to
show increased vascularity as opposed to benign lesions.
Also it appears that this increased vascularity is indepen-
dent of patient age.
The lack of association between site or side of the lesion
and malignancy found in our study is in agreement with the
results of McNicholas et al [11].
In our study we found a significantly larger size lesion
among malignant groups as opposed to the benign group.
This finding is in contrary to previous studies performed by
Ozdemir et al [13] and Sehgal et al [10]. However, these
differences in results should be interpreted with caution
because it is logical to assume that the malignant lesions
tend to grow larger at a much quicker rate than the benign
lesions. The longer the period between the actual occur-
rence of the tumor and seeking of medical help by the
patient, the greater the probability of finding largermalignant lesions as compared to benign lesions. Never-
theless, our data indicate that the relationship between the
size and RI value of tumors was weak and nonsignificant.
In this study, we found a higher RI in the malignant
group. The RI of 0.625 was identified as a threshold with
88% of sensitivity in diagnosing malignancy. However in
spite of previous studies, this threshold was not statistically
significant. Lee et al [15] reported that RI of 0.78 was a
suitable threshold for distinguishing malignant from benign
tumors. Choi et al observed that, in more than 80% of ma-
lignant breast nodules, the RI exceeded 0.70 with a sensi-
tivity of 80.9% and specificity of 89.1% [12]. However, they
also concluded that this threshold could not be used alone
and a biopsy is the gold standard for diagnosis. Peters-Engl
et al [16] have also reported that RI of 0.70 is the best cut-
off value for differentiating malignant nodules, with 82%
sensitivity, 81% specificity, 70% positive predictive value
and 89% negative predictive value. Konishi et al [17] and
Madjar et al [18] reported that a threshold of 0.75 and 0.7
was the suitable cut-off, respectively. After 1 decade, in
spite of the technological development, similar results
were concluded from the more recent studies. Schmille-
vitch et al [19] proposed RI cut-off value of 0.69 with 84.2%
sensitivity and 88.9% specificity.
The difference between the cut-off points of RI and the
discrepancy between sensitivity and specificity proposed in
different studies and our study could be explained by the
fact that the behavior of a tumor depends on its vascularity.
The fact that the majority of our cases were invasive ductal
carcinoma and most of the benign lesions in our study were
fibroadenoma could be responsible for the disparity be-
tween the results of our study and those of the prior ones.
The majority of benign lesions were fibroadenoma, and, in
the malignant group, 15 out of 18 cases were invasive
ductal carcinoma. There was very little other pathology in
either benign or malignant groups. This made it impossible
to analyze the impact of the tumor type of the RI. Never-
theless, a larger size study with a greater number of vari-
ants of malignant and benign tumors could have allowed a
better insight on the effect of tumor types on RI. Another
potential reason would be the difference between the age
of the groups with malignant and benign breast lesions in
most of the mentioned studies. As discussed earlier, the age
of the patients might affect the vascularity of the breast
lesion. The same could be proposed for RI of the tumoral
vessels. Given the various types of carcinomas, different
patterns of vascularization, different grades of differenti-
ation, varying types of benign lesions, age and ethnicity
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in blood flow, and many other possible factors, it might be
practically pointless to identify an absolute value for
differentiating malignant from benign lesions within
different studies. Further studies with larger sample sizes
and covering more factors using multivariate logistic
regression are needed. We especially recommend studies
on age-matched benign and malignant breast lesions to be
able to have more definite results.
In conclusion, CDUS is a useful tool in predicting malig-
nancy in breast lesions. Hypervascularity of a breast mass is
the most reliable sign in Doppler ultrasound to predict its
malignancy. However, it appears that the use of RI alone
has little value in differentiating between malignant and
benign breast lesions, and pathological findings are still the
gold standard for diagnosing the type of breast nodules.
Larger sized human studies are needed to elucidate further
the potential benefits of CDUS in evaluating breast lesions.
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